Myriad Genetics

Filed a patent for "multiple-ancestry polygenic risk assessment for breast cancer" on Fri, July 7, 2023

Filed a patent for "method of predicting the absolute risk reduction from androgen deprivation therapy added to radiation therapy in patients with prostate cancer" on Wed, May 24, 2023

Filed a patent for "electronic variant classification" on Thu, August 22, 2024

Filed a patent for "method of using biomarkers and clinical variables for predicting chemotherapy benefit" on Thu, April 13, 2023

Filed a patent for "polygenic trait prediction using local ancestry" on Thu, August 17, 2023

Filed a patent for "signatures for predicting cancer immune therapy response" on Thu, March 30, 2023

Filed a patent for "methods and materials for assessing homologous recombination deficiency in breast cancer subtypes" on Thu, July 6, 2023

Filed a patent for "methods and materials for assessing homologous recombination deficiency" on Thu, April 20, 2023

Filed a patent for "methods and materials for assessing loss of heterozygosity" on Thu, April 13, 2023

Filed a patent for "comprehensive polygenic risk prediction for breast cancer" on Thu, June 1, 2023

Filed a patent for "global polygenic risk assessment for breast cancer" on Wed, August 16, 2023

Filed a patent for "cancer biomarkers" on Thu, June 6, 2024